Skip to main content

Table 1 Baseline characteristics and in-hospital outcome

From: Prognostic value of procalcitonin in patients after elective cardiac surgery: a prospective cohort study

Characteristic Patients without delayed complications (n = 634) Patients with delayed complications (n = 117) p value
Demographics
Gender (n) (%)
Male 445 (70) 74 (65) 0.16
Age (years) 61.5 ± 15.2 67.7 ± 11.6 <0.001
Weight (kg) 82.6 ± 15.1 81.5 ± 81.5 0.26
Size (cm) 173 ± 9.6 171 ± 9.0 0.11
Body mass index (kg/m2) 27.7 ± 4.5 27.7 ± 4.9 0.76
eGFR (CKD-EPI) 86.7 ± 33.8 70.0 ± 32.4 <0.001
EuroSCORE 2 4.9 ± 5.6 8.0 ± 6.9 <0.001
Ejection fraction (%) 60.3 ± 13.9 55.4 ± 16.2 0.009
NYHA class 2.9 ± 0.5 2.9 ± 0.6 0.39
Comorbidity
Coronary artery disease (n) (%) 258 (41) 57 (49) 0.13
Pulmonary hypertension (n) (%) 122 (19) 34 (29) 0.019
COPD (n) (%) 34 (5) 10 (9) 0.20
Status past stroke (n) (%) 23 (4) 4 (4) 1
Insulin-dependent diabetic (n) (%) 27 (4) 10 (9) 0.061
Intraoperative
Procedure type (n) (%)
CABG surgery 228 (36) 49 (42) 0.25
Valve surgery 442 (70) 92 (79) 0.059
Combination surgery 183 (29) 55 (47) <0.001
Redo CABG and/or valve 68 (11) 12 (10) 1
Operation time (min) 159 ± 44.5 189 ± 63.8 <0.001
CPB time (min) 77 ± 28.6 100 ± 42.1 <0.001
Outcome
Mech. ventilated (h) (min–max) 5.0 ± 2.1 35.4 ± 102 <0.001
Length of stay (days)
In ICU (days) (min–max) 0.9 ± 0.3 3.1 ± 6.0 <0.001
In hospital (days) (min–max) 9.3 ± 1.6 20.1 ± 11.3 <0.001
Hospital mortality (%) 0 (0) 4 (3) 0.001
  1. Data are expressed as mean ± standard deviation
  2. Statistically significant p values are in italics (p < 0.05)
  3. eGFR (CKD-EPI) glomerular filtration rates, calculated by CKD-EPI-formula (Chronic Kidney Disease Epidemiology Collaboration). NYHA class New York Heart Association functional classification, COPD chronic obstructive pulmonary disease, CABG surgery coronary artery bypass grafting surgery, CPB time cardiopulmonary bypass time, ICU intensive care unit